Business Context and Reporting Period
This Form 8-K is a current report filed by Graybug Vision, Inc. (not Calcimedica, Inc.) on June 4, 2021. The filing reports on the results of the Company's 2021 Annual Meeting of Stockholders held on June 2, 2021. Graybug Vision is an emerging growth company incorporated in Delaware, with its common stock trading on the Nasdaq Global Market under the symbol "GRAY."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and does not contain financial performance data.
Material Changes and Voting Results
The filing details the adoption of two proposals at the Annual Meeting:
- Election of Director: Christy Shaffer, Ph.D., was elected as a Class I director for a three-year term expiring in 2024.
- Shares For: 11,385,601
- Shares Withheld/Abstaining: 275,471
- Broker Non-Votes: 3,372,431
- Ratification of Auditors: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified.
- Shares For: 14,976,016
- Shares Against: 27,736
- Shares Withheld/Abstaining: 29,751
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of stockholder vote outcomes.
Important Facts for Investors to Verify
- Verify the correct registrant name is Graybug Vision, Inc., as the input metadata incorrectly referenced Calcimedica, Inc.
- Confirm the high number of broker non-votes (3,372,431) regarding the director election, which indicates shares held in street name where brokers lacked discretionary voting authority.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K contains none.
- Note the Company's status as an emerging growth company, which may affect its financial reporting requirements.